Camorani S, Passariello M, Agnello L, Esposito S, Collina F, Cantile M, Di Bonito M, Ulasov IV, Fedele M, Zannetti A, De Lorenzo C, Cerchia L
* Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer (32 visite) (PDF 20 visite)
J Exp Clin Cancer Res, 2020 Sep 7; 39(1): 180-180.
Impact Factor: 7.068
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russi S, Verma HK, Laurino S, Mazzone P, Storto G, Nardelli A, Zoppoli P, Calice G, La Rocca F, Sgambato A, Lucci V, Falco G, Ruggieri V
* Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells (134 visite)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2019 Jul 31; 20(15): N/D-N/D.
Impact Factor: 4.183
Dettagli    Esporta in BibTeX    Esporta in EndNote

Orlandella FM, Mariniello RM, Iervolino PLC, Auletta L, De Stefano AE, Ugolini C, Greco A, Mirabelli P, Pane K, Franzese M, Denaro M, Basolo F, Salvatore G
* Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 alpha/beta pathways (161 visite)
Mol Carcinog (ISSN: 0899-1987linking), 2019 Mar 4; 58(7): 1181-1193.
Impact Factor: 3.851
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bolzati C, Salvarese N, Carpanese D, Seraglia R, Melendez-alafort L, Rosato A, Capasso D, Saviano M, Del Gatto A, Comegna D, Zaccaro L
* [(99m)Tc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alphavbeta3 Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies (269 visite)
J Med Chem (ISSN: 0022-2623linking, 0022-2623print, 1520-4804electronic), 2018 Nov 8; 61(21): 9596-9610.
Impact Factor: 6.253
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camorani S, Hill B, Collina F, Gargiulo S, Napolitano M, Cantile M, Di Bonito M, Botti G, Fedele M, Zannetti A, Cerchia L
* Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer (542 visite) (PDF 114 visite)
Theranostics (ISSN: 1838-7640, 1838-7640electronic, 1838-7640linking), 2018 Oct 6; 8(18): 5178-5199.
Impact Factor: 8.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Comegna D, Zannetti A, Del Gatto A, De Paola I, Russo L, Di Gaetano S, Liguoro A, Capasso D, Saviano M, Zaccaro L
* Chemical Modification for Proteolytic Stabilization of the Selective alphavbeta3 Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells (771 visite) (PDF 171 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2017 Dec 14; 60(23): 9874-9884.
Impact Factor: 6.253
Dettagli    Esporta in BibTeX    Esporta in EndNote

Depalo N, Corricelli M, De Paola I, Valente G, Iacobazzi RM, Altamura E, Debellis D, Comegna D, Fanizza E, Denora N, Laquintana V, Mavelli F, Striccoli M, Saviano M, Agostiano A, Del Gatto A, Zaccaro L, Curri ML
* NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging (254 visite) (PDF 144 visite)
Acs Appl Mater Inter (ISSN: 1944-8244), 2017 Dec 13; 9(49): 43113-43126.
Impact Factor: 8.097
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camorani S, Hill BS, Fontanella R, Greco A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E, Cerchia L, Zannetti A
* Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRbeta Aptamer (575 visite) (PDF 183 visite)
Theranostics (ISSN: 1838-7640, 1838-7640electronic), 2017 Aug 22; 7(14): 3595-3607.
Impact Factor: 8.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Hill BS, Pelagalli A, Passaro N, Zannetti A
* Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype (240 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2017 Aug 14; 8(42): 73296-73311.
Impact Factor: 5.168
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camorani S, Crescenzi E, Gramanzini M, Fedele M, Zannetti A, Cerchia L
* Aptamer-mediated impairment of EGFR-integrin alphavbeta3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers (324 visite) (PDF 190 visite)
Sci Rep (ISSN: 2045-2322, 2045-2322electronic, 2045-2322linking), 2017 Apr 20; 7: 46659-46659.
Impact Factor: 4.122
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A
* A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (813 visite) (PDF 255 visite)
Cancer Lett (ISSN: 0304-3835), 2015 Oct 27; 370(1): 100-107.
Impact Factor: 7.36
Dettagli    Esporta in BibTeX    Esporta in EndNote

Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G, Martinelli R, Sorrentino A, Di Pace A, Mascolo M, Bisogni R, Scalvenzi M, Alfano B, Romano  M
* FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential (298 visite) (PDF 212 visite)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2013 Apr 4; 4(6): e578-e578.
Impact Factor: 5.333
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pisano M, De Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C
* In vitro activity of the alphavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells (297 visite)
Anticancer Res (ISSN: 0250-7005, 0250-0700, 1791-7530electronic), 2013 Mar; 33(3): 871-879.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C, Zaccaro L, Iaccarino G
* Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit (354 visite)
J Transl Med Journal Of Translational Medicine (ISSN: 1479-5876electronic), 2011 Jan 13; 9: 7-7.
Impact Factor: 3.474
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nappi C\r -, Megna R\r -, Acampa W\r -, Assante R\r -, Zampella E\r -, Gaudieri V\r -, Mannarino T\r -, Green R\r -, Cantoni V\r -, Petretta M\r -, Cuocolo A\r -, Carli E\r -, Caviglia Gp\r -, Pellicano R\r -, Fagoonee S\r -, Rizza S\r -, Astegiano M\r -, Saracco Gm\r -, Ribaldone Dg\r -, Belli S\r -, Franco P\r -, Iommelli F\r -, De Vincenzo A\r -, Brancaccio D\r -, Telesca M\r -, Merlino F\r -, Novellino E\r -, Ranson M\r -, Del Vecchio S\r -, Grieco P\r -, Carotenuto A\r -, Stoppelli Mp\r -, Cassiano Mt\r -, Lanzillo R\r -, Alfano B\r -, Costabile T\r -, Comerci M\r -, Prinster A\r -, Moccia M\r -, Megna R\r -, Morra Vb\r -, Quarantelli M\r -, Brunetti A\r -, Scarpellini E\r -, Fagoonee S\r -, Rinninella E\r -, Rasetti C\r -, Aquila I\r -, Larussa T\r -, Ricci P\r -, Luzza F\r -, Abenavoli L\r -, Camorani S\r -, Passariello M\r -, Agnello L\r -, Esposito S\r -, Collina F\r -, Cantile M\r -, Di Bonito M\r -, Ulasov Iv\r -, Fedele M\r -, Zannetti A\r -, De Lorenzo C\r -, Cerchia L\r -, Liuzzi R\r -, Piccolo
- Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. - Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. - Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides. - Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis. - Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. - Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer. - Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy. - Brain Plasticity in Charcot-Marie-Tooth Type 1A Patients? A Combined Structural and Diffusion MRI Study. - Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy (16 visite)
J Clin Med 2020 Jul 23 9 (ISSN: 1033-90jcm9082353pharmaceuticalsbasel2020sep301310, 1033-90ph13100284 scirep2020jan2110, 1010-38s41598020578202 oncotargetsther2020feb1413), N/D; (-1619-7070(Print): N/D-N/D.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote